Skip to main content
. 2022 Aug 12;20:365. doi: 10.1186/s12967-022-03567-5

Fig.3.

Fig.3

Fluctuating changes of genomic alterations during sequential chemotherapy. A: changes of percentages of TP53 and LRP1B mutations during treatment. B: fluctuating changes of TP53 and LRP1B frequency during treatment. C: involved mutation sites of TP53 and LRP1B